Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance-Reference-Cited by-同舟云学术

Serious adverse events reported for antiobesity medicines: postmarketing experiences from the EU adverse event reporting system EudraVigilance

Published:2016-08-01 Issue:11 Volume:40 Page:1742-1747
ISSN:0307-0565
Container-title:International Journal of Obesity
language:en
Short-container-title:Int J Obes

Author:

Aagaard L,Hallgreen C E,Hansen E H

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

http://www.nature.com/articles/ijo2016135.pdf

Reference44 articles.

1. Kang JG, Park CY . Anti-obesity drugs: a review about their effects and safety. Diabetes Metab J 2012; 36: 13–25.

2. Haddock CK, Poston WS, Dill PL, Foreyt JP, Ericsson M . Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes Relat Metab Disord 2002; 26: 262–273.

3. Glazer G . Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety. Arch Intern Med 2001; 161: 1814–1824.

4. European Court of Justice. Case C-39/03 P Artegodan GmbH vs. The Commission. T-74/00. Available at: http://www.europa.eu (last accessed 17 April 2016).

5. Cheung BM, Cheung TT, Samaranayake NR . Safety of antiobesity drugs. Ther Adv Drug Saf 2013; 4: 171–181.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Obesity Effect of Auricularia delicate Involves Intestinal-Microbiota-Mediated Oxidative Stress Regulation in High-Fat-Diet-Fed Mice;Nutrients;2023-02-08

2. Analysis of 15 anti-obesity drugs in urine using thermal-assisted paper spray mass spectrometry;Analytical Methods;2023

3. Drivers of medicalization in the Canadian Adult Obesity Clinical Practice Guidelines;Canadian Journal of Public Health;2022-07-15

4. Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020;International Journal of Clinical Pharmacy;2021-09-26

5. Clinical outcomes associated with anti‐obesity medications in real‐world practice: A systematic literature review;Obesity Reviews;2021-08-22